“Charlie’s Law” Benefits Regenerative Medicine and Stem Cell Research in Texas
Director of Regenerative Medicine Research Doris Taylor, Ph.D., joined Texas lawmakers on a panel last week to discuss “Charlie’s Law,” which was passed unanimously by the state legislature during the 85th Legislative Session this summer. Charlie’s Law, the first of its kind in the United States, allows patients with chronic or terminal illnesses to access experimental stem cell interventions in Texas.
The panel, hosted by the Texas Heart Institute and the Baker Institute for Health and Biosciences, gathered to discuss the effects of Charlie’s Law on health care and research. “One of the benefits of this law is that it is going to give us a lot more data,” said Taylor, who has over two decades of experience researching stem cells and regenerative medicine, in an interview with TMC News. Read more about Charlie’s Law and the panel discussion here.
To see more photos from the event, click here.